HYTRIN Drug Patent Profile

✉ Email this page to a colleague

When do Hytrin patents expire, and what generic alternatives are available?

Hytrin is a drug marketed by Abbott and is included in two NDAs.

The generic ingredient in HYTRIN is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Hytrin

A generic version of HYTRIN was approved as terazosin hydrochloride by APNAR PHARMA LP on March 30^th, 1998.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for HYTRIN?
What are the global sales for HYTRIN?
What is Average Wholesale Price for HYTRIN?

Summary for HYTRIN

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	260
Clinical Trials:	4
Patent Applications:	3,981
DailyMed Link:	HYTRIN at DailyMed

Drug patent expirations by year for HYTRIN

Recent Clinical Trials for HYTRIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Iowa	Phase 1
Michael J. Fox Foundation for Parkinson's Research	Phase 1
University of Iowa	Phase 1/Phase 2

See all HYTRIN clinical trials

US Patents and Regulatory Information for HYTRIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-001	Dec 14, 1994		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-003	Aug 7, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-004	Dec 14, 1994		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-004	Aug 7, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for HYTRIN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-003	Dec 14, 1994	⤷ Sign Up	⤷ Sign Up
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-004	Dec 14, 1994	⤷ Sign Up	⤷ Sign Up
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-004	Aug 7, 1987	⤷ Sign Up	⤷ Sign Up
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-003	Dec 14, 1994	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for HYTRIN

See the table below for patents covering HYTRIN around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Germany	69500064		⤷ Sign Up
Denmark	0536329		⤷ Sign Up
Switzerland	635096	CHLORHYDRATE DIHYDRATE DE 1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-TETRAHYDROFUROYL)PIPERAZINE ET MEDICAMENT LE CONTENANT.	⤷ Sign Up
United Kingdom	1517403		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for HYTRIN

Recent Clinical Trials for HYTRIN

Make Better Decisions: Try a trial or see plans & pricing